Latest news
Loading news…
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Global Blood Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Global Blood Therapeutics was acquired by Pfizer in 2022 for $5.4B.
Total Funding
$803.8M
Funding Rounds
5
Last Funding
Acquisitions
0
Monthly Visits
Contacts
326
About Global Blood Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- South San Francisco, California, United States
Global Blood Therapeutics Funding Rounds
5 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 5Show
Page 1 / 1
Global Blood Therapeutics Key People
Founder
Director, Clinical Outsourcing
Executive Vice President
Chief Scientific Officer
326
professional contacts at Global Blood Therapeutics
Contact execs at Global Blood Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Global Blood Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.